SCHEMBL7318937

SCHEMBL7318937

Clc1cc(CCc2ccccn2)c2oc(-c3ccsc3)nc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 4/20 0.38
NPC1 O15118 4/20 0.36
RAB9A P51151 3/20 0.36
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 2/20 0.36
PDE3A Q14432 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TP53 P04637 1/20 0.35
HPGD P15428 1/20 0.35
PDGFRB P09619 3/20 0.34
PDGFRA P16234 3/20 0.34
MAPT P10636 3/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7322971 0.87 NPC1 (0.41) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL7323231 0.83 ALDH1A1 (0.43) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL7314123 0.82 KDM4E (0.37) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL7317091 0.82 PDGFRB (0.38) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL7321855 0.80 KDM4E (0.36) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL7315804 0.79 ALDH1A1 (0.36) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL7325321 0.79 ADORA2A (0.49) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL7324750 0.78 STAT6 (0.38) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL7324311 0.78 KDM4E (0.40) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL7315751 0.78 RAB9A (0.43) NPC1RAB9AKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166041-A 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma EURO-CELTIQUE, S.A. (LU) 2000-12-26 US claimed
US-6166041-A 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma EURO-CELTIQUE, S.A. (LU) 2000-12-26 US disclosed